Aslan Pharmaceuticals Ltd ADR (NQ: ASLN )

1.920 USD +0.020 (+1.05%)

Official Closing Price Updated: 7:02 PM EST, Jan 15, 2021 Add to My Watchlist

Price and Volume

Volume	201,400
Open	1.880
Bid (Size)	1.960 (10)
Ask (Size)	1.990 (19)
Prev. Close	1.900
Today's Range	1.880 - 1.960
52wk Range	0.8300 - 2.850
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

ASLAN Pharmaceuticals Opens Expansion Cohort in ASLAN004 Atopic Dermatitis Clinical Trial

January 11, 2021

ASLAN Pharmaceuticals to Present at Upcoming Piper Sandler Investor Conference

November 19, 2020

Performance

YTD	+3.23%	+3.23%
1 Month	-7.69%	-7.69%
3 Month	-6.34%	-6.34%
6 Month	-5.88%	-5.88%
1 Year	-31.43%	-31.43%

More News

ASLAN Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update

November 09, 2020

ASLAN Pharmaceuticals Initiates Third Dose Cohort of ASLAN004 in Atopic Dermatitis Clinical Trial

October 22, 2020

ASLAN Pharmaceuticals to Develop ASLAN003 as Next Generation DHODH Inhibitor in Autoimmune Conditions

October 16, 2020

ASLAN Pharmaceuticals Completes Enrolment in Second Cohort and Opens New Sites in US and Australia in ASLAN004 Atopic Dermatitis Study

September 21, 2020

ASLAN Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference

September 10, 2020

ASLAN Pharmaceuticals Resumes Recruitment of New Patients Into ASLAN004 Study

August 24, 2020

ASLAN Pharmaceuticals to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference 2020

August 07, 2020

ASLAN Pharmaceuticals Appoints Kenneth Kobayashi, MD, as Chief Medical Officer

August 03, 2020

12 Healthcare Stocks Moving In Friday's After-Market Session

October 16, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.